Immune cells in triple-negative breast cancer offer potential therapeutic target

New research led by the University of Pennsylvania School of Veterinary Medicine’s Rumela Chakrabarti reveals how immune cells called myeloid-derived immunosuppressor cells contribute to the progression of triple-negative breast cancer, a particularly aggressive form of the disease. Pairing chemotherapy with a drug that blocks these cells may one day help stem the cancer’s spread.

Go to Source

(Visited 1 times, 1 visits today)

Site Footer

Sliding Sidebar